Eastern Bank Has Raised By $442,234 Its Amgen (AMGN) Position; Mondelez International Has 0.92 Sentiment

August 4, 2017 - By wolcottdaily

Eastern Bank increased Amgen Inc (AMGN) stake by 4.01% reported in 2016Q4 SEC filing. Eastern Bank acquired 3,029 shares as Amgen Inc (AMGN)’s stock declined 9.68%. The Eastern Bank holds 78,657 shares with $11.50M value, up from 75,628 last quarter. Amgen Inc now has $127.09B valuation. The stock decreased 0.16% or $0.28 during the last trading session, reaching $174.18. About shares traded. Amgen, Inc. (NASDAQ:AMGN) has risen 5.27% since August 4, 2016 and is uptrending. It has underperformed by 11.43% the S&P500.

Mondelez International, Inc. is a snack company. The company has market cap of $65.87 billion. The Firm makes and markets snack food and beverage products for consumers. It has a 38.96 P/E ratio. It operates through four divisions: Latin America, Asia, Middle East, and Africa , Europe and North America.

Eastern Bank decreased Morgan Stanley (NYSE:MS) stake by 8,304 shares to 380,291 valued at $16.07M in 2016Q4. It also reduced I Shares (LQD) stake by 24,621 shares and now owns 14,180 shares. Invesco Ltd. (NYSE:IVZ) was reduced too.

Among 21 analysts covering Amgen Inc. (NASDAQ:AMGN), 10 have Buy rating, 0 Sell and 11 Hold. Therefore 48% are positive. Amgen Inc. has $218 highest and $160 lowest target. $189.33’s average target is 8.70% above currents $174.18 stock price. Amgen Inc. had 53 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Market Perform” rating by Wells Fargo given on Friday, December 4. Piper Jaffray upgraded the shares of AMGN in report on Thursday, November 5 to “Overweight” rating. On Thursday, October 29 the stock rating was maintained by UBS with “Buy”. The firm has “Market Perform” rating given on Friday, February 5 by Leerink Swann. On Monday, June 26 the stock rating was maintained by Oppenheimer with “Buy”. The stock of Amgen, Inc. (NASDAQ:AMGN) earned “Outperform” rating by RBC Capital Markets on Friday, July 31. On Saturday, August 29 the stock rating was maintained by Piper Jaffray with “Overweight”. As per Tuesday, December 13, the company rating was initiated by Oppenheimer. The stock of Amgen, Inc. (NASDAQ:AMGN) earned “Neutral” rating by Citigroup on Friday, July 29. The firm earned “Overweight” rating on Tuesday, December 15 by Morgan Stanley.

Investors sentiment decreased to 1.09 in 2016 Q4. Its down 0.17, from 1.26 in 2016Q3. It turned negative, as 98 investors sold AMGN shares while 488 reduced holdings. 111 funds opened positions while 527 raised stakes. 561.98 million shares or 1.23% less from 568.98 million shares in 2016Q3 were reported. Koshinski Asset Mngmt invested in 10,072 shares. Teacher Retirement System Of Texas stated it has 0.76% of its portfolio in Amgen, Inc. (NASDAQ:AMGN). Avalon Advsrs holds 0.81% or 153,152 shares. Oregon Pub Employees Retirement Fund stated it has 77,861 shares. Kcg Incorporated invested 0.04% of its portfolio in Amgen, Inc. (NASDAQ:AMGN). State Bank Of America De reported 5.47M shares. Sheets Smith Wealth Management, North Carolina-based fund reported 1,609 shares. 53,298 were accumulated by Jlb Assoc. Cannell Peter B & holds 8,585 shares. Sentinel Asset Mngmt invested in 210,400 shares. Loeb Prtnrs holds 0.39% in Amgen, Inc. (NASDAQ:AMGN) or 7,800 shares. Pinebridge Ltd Partnership holds 25,076 shares or 0.11% of its portfolio. Palladium Prtn Limited Co reported 1.36% stake. Mason Street Ltd Llc has 101,765 shares for 0.4% of their portfolio. Trillium Asset has invested 0.02% in Amgen, Inc. (NASDAQ:AMGN).

Since May 24, 2017, it had 0 insider buys, and 2 selling transactions for $1.02 million activity. $451,164 worth of Amgen, Inc. (NASDAQ:AMGN) was sold by Patton Cynthia M on Wednesday, May 24. $569,541 worth of Amgen, Inc. (NASDAQ:AMGN) shares were sold by BALTIMORE DAVID.

Since January 1, 0001, it had 1 insider purchase, and 4 insider sales for $77.87 million activity.

The stock decreased 1.56% or $0.69 during the last trading session, reaching $43.41. About shares traded. Mondelez International Inc (MDLZ) has risen 5.69% since August 4, 2016 and is uptrending. It has underperformed by 11.01% the S&P500.

Lindsell Train Ltd holds 25.77% of its portfolio in Mondelez International Inc for 11.77 million shares. Trian Fund Management L.P. owns 44.23 million shares or 17.67% of their US portfolio. Moreover, Pershing Square Capital Management L.P. has 17.2% invested in the company for 22.94 million shares. The Hong Kong-based Hillhouse Capital Management Ltd. has invested 8.8% in the stock. Ratan Capital Management Lp, a New York-based fund reported 200,000 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

  • Learning Technologies Group PLC (LTG) Jumps 1.49% on Aug 7
  • Bnp Paribas Investment Partners Sa Cut Its Yum Brands (YUM) Position; Gamco Investors (GBL)’s Sentiment Is 1.32
  • EPS for Catalent (CTLT) Expected At $0.56; Hound Partners Lifted Its Century Alum Co (CENX) Position
  • Analysts See $1.28 EPS for National Bank of Canada (NA); Last Week RBC Bearings (ROLL) Analysts
  • CBOE Holdings (CBOE) Hold Rating Kept at KBW; With $94.0000 Target; RVUE HOLDINGS (RVUE) SI Decreased By 74.63%
  • Tower Bridge Advisors Trimmed Microsoft (MSFT) Position By $676,606; Nuveen Asset Management Has Lowered By $615,000 Its Spectra Energy (Call) (SE) Stake
  • First Analysis Reports Initiation of Coupons.com (COUP) with $37.00 Target; 2 Analysts Bullish Gladstone Investment (GAIN)
  • salesforce.com, inc. (CRM) EPS Estimated At $0.09; Profile of 0 Analysts Covering Capitol Federal Financial, Inc. (CFFN)
  • Installed Building Products (IBP) “Outperform” Rating Reconfirmed by RBC Capital Markets; With $69.00 Target; Shorts at Ritter Pharmaceuticals (RTTR) Raised By 5.66%
  • H.C. Wainwright Starts Nektar Therapeutics (NDAQ:NKTR) Coverage with $31.00 Target; Etrade Capital Management Has Lowered Dycom Inds (DY) Holding
Twitter Auto Publish Powered By : XYZScripts.com